指南与共识流行病学与生物统计基础与转化研究

临床指南中预测模型的纳入与预期用途:四国五领域系统综述

The inclusion and intended use of prediction models in clinical guidelines: a systematic review of five clinical domains in four countries.
指南 / 共识 · J Clin Epidemiol · 2026-04-21

该系统综述评估了美国、英国、加拿大和荷兰四国五个临床领域(肺栓塞、子痫前期、脓毒症、痴呆和肺癌)的临床指南对预测模型的纳入情况,并比较模型开发/验证研究中的预期用途与指南推荐之间的一致性。共纳入20部指南,识别出9个独特预测模型,这些模型在59项研究中进行了外部验证。研究发现指南对预测模型的推荐有限,且指南推荐与模型开发或验证时的预期用途存在较大差异。

要点

  • 指南对预测模型的推荐频率因领域而异,肺栓塞最高(4/4),痴呆最低(0/4)。
  • 指南推荐与模型开发/验证时的预期用途在临床背景、使用时机和目标人群上常不一致。
  • 需要标准化预测模型纳入指南的方法,确保推荐与预期用途及验证证据一致。

核心结论

  • 临床指南偶尔推荐使用预测模型,但许多指南对如何操作化这些模型提供有限指导。
  • 指南推荐常与模型开发或验证时的预期用途不一致,尤其在临床背景、使用时机和目标人群方面。
  • 需要更大程度的标准化来将预测模型纳入指南,并确保推荐用途与预期目的和验证证据一致。

研究设计与样本

  • 系统综述,覆盖四个国家(美国、英国、加拿大、荷兰)的五个临床领域(肺栓塞、子痫前期、脓毒症、痴呆、肺癌)的临床指南。
  • 共纳入20部临床指南,识别出9个独特预测模型,这些模型在59项研究中进行了外部验证。
  • 对于指南中纳入的每个预测模型,识别相应的模型开发和验证研究,并从指南、开发论文和外部验证论文中提取临床设置和预期用途数据。

主要发现

  • 肺栓塞领域指南纳入预测模型频率最高(4/4),其次为脓毒症(3/4),肺癌和子痫前期(各1/4),痴呆(0/4)。
  • 共识别出9个独特预测模型,在59项研究中进行了外部验证。
  • 发现模型开发或验证研究中的设置和预期用途与指南提供的指导之间存在较大差异,特别是在临床背景/设置、使用时机和特定患者人群方面。

临床怎么用

  • 临床指南在推荐预测模型时应明确其预期用途、使用时机和目标人群,并与开发/验证证据保持一致。
  • 指南制定者需标准化预测模型的纳入方法,提供可操作的使用指导。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Prediction models can be used to support medical decision-making, but their integration into clinical guidelines remains unclear. Despite the abundance of published models, it is unknown how many are included in clinical guidelines and whether their recommended use in the guideline aligns with model's intended use at development. We investigated the inclusion of prediction models in clinical guidelines and examined any discrepancies between the intended use described in the model development or validation studies and their recommendation in the clinical guidelines in which they are mentioned. STUDY DESIGN AND SETTING: We systematically reviewed clinical guidelines across five clinical domains (pulmonary embolism, preeclampsia, sepsis, dementia, and lung cancer) in four countries (the United States, the United Kingdom, Canada, and the Netherlands). For each prediction model included in the guideline, we identified the corresponding model development and validation studies. Data on clinical setting and intended use of the prediction model were extracted from the guidelines, the development and external validation papers. RESULTS: A total of 20 clinical guidelines were included, identifying nine unique prediction models that were externally validated in 59 studies. Pulmonary embolism had the highest frequency of prediction models in guidelines (4/4), followed by sepsis (3/4), lung cancer and preeclampsia (both 1/4), and dementia (0/4). We identified large discrepancies between the setting and intended use of the models at development or in validation studies, and the guidance provided in guidelines, particularly on aspects such as the clinical context/setting, the timing of use, and the specific patient population. CONCLUSION: Clinical guidelines occasionally recommended the use of prediction models. Many guidelines provided limited instructions on how to operationalize these models and often recommended using the model in a specific clinical scenario without addressing any further key differences from development or validation. When included, typically there were inconsistencies between the intended use of the model and guideline recommendation. There is need for greater standardization in how prediction models are incorporated into guidelines, and to ensure that their recommended use aligns with their intended purpose and validation evidence.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. de Kanter E, Vernooij RWM, Huis In 't Veld L, et al. The inclusion and intended use of prediction models in clinical guidelines: a systematic review of five clinical domains in four countries. J Clin Epidemiol. 2026. PMID: 42025974. doi:10.1016/j.jclinepi.2026.112288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。